Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study
Abstract Background Mechanisms causing non-response to biological agents in IBD remain to be fully understood. Thus, we aimed to characterize the lipid profile in treatment refractory non-immunogenic patients with adequate trough-levels. Methods Patients with IBD refractory to treatment with anti-tu...
Saved in:
| Main Authors: | Øystein K. Moe, Qian Gao, Dawei Geng, Einar Jensen, Rasmus Goll, Oddmund Nestegard, Mona D. Gundersen, Jon R. Florholmen, T. Moritz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-03944-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling the influence of lipidomes on inflammatory bowel disease: a bidirectional mendelian randomization study
by: Hang Lei, et al.
Published: (2025-04-01) -
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
by: Oddmund Nestegard, et al.
Published: (2022-01-01) -
The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab
by: Rebecka Ventin-Holmberg, et al.
Published: (2025-08-01) -
The colonic mucosal virome in inflammatory bowel disease reveals Crassvirales depletion and disease-specific virome features
by: Austin Yan, et al.
Published: (2025-12-01) -
Clinical peculiarities of antibiotic associated bowels impairment and its significance in irritable bowel syndrome appearance
by: І. O. Pasichna, et al.
Published: (2016-06-01)